CHMP4C as a Novel Marker Regulates Prostate Cancer Progression through Cycle Pathways and Contributes to Immunotherapy

Researchers investigated the expression and clinical prognosis of charged multivesicular protein (CHMP) 4C and explored its potential regulatory mechanism in prostate cancer.
[Frontiers In Oncology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News